Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. (CLPT) Stock Overview

Explore ClearPoint Neuro, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CLPT●NASDAQ
HealthcareMedical - Devices
$15.39
$0.57(3.57%)
U.S. Market opens in 62h 58m

ClearPoint Neuro, Inc. (CLPT)

Meyka AI Score

Z

Key Financials

Market Cap455.5M
P/E Ratio-13.01
EPS (TTM)$-1.18
ROE-1.88%
Fundamental Analysis

AI Price Forecasts

1 Month$17.93
3 Months$15.60
1 Year Target$17.76

CLPT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of ClearPoint Neuro, Inc. (NASDAQ: CLPT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ClearPoint Neuro, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CLPT on the NASDAQ shows an RSI of 52.16, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.76 for the NASDAQ listing.

Key metrics behind ClearPoint Neuro, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.01 and a market capitalization of 455.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLPT on the NASDAQ.

Price Performance (NASDAQ: CLPT)

1-Day Change
1.32%
5-Day Change
-1.28%
1-Month Change
-0.13%
3-Month Change
31.54%
6-Month Change
8.76%
Year-to-Date (YTD) Change
12.50%
1-Year Change
50.29%
3-Year Change
174.82%
5-Year Change
-14.64%
All-Time (Max) Change
-48.70%

Contact Information

https://www.clearpointneuro.com
888 287 9109
120 S. Sierra Avenue, Solana Beach, CA, 92075

Company Facts

1,720 Employees
IPO DateMay 22, 2012
CountryUS
Actively Trading

Frequently Asked Questions